Patient-Focused Drug Development Events May Be Giving Way To Small, Private Meetings With FDA

12 Aug 2022

Patient listening sessions, which are easier to schedule, have overtaken traditional patient-focused drug development meetings in terms of volume, although US FDA’s data may be incomplete.

Small meeting — The private, and smaller, patient listening sessions can be scheduled faster than traditional patient-focused drug development meetings. • Source: Shutterstock

Patient-Focused Drug Development Events May Be Giving Way To Small, Private Meetings With FDA

More from R&D

More from Pink Sheet